Pay in 4 interest-free payments of $7.11 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
HHS has announced that GHK-Cu is expected to return to Category 1, which would restore compounding access for injectable formulations. BPC-157 On 23 July 2026, PCAC voted to recommend adding BPC-157 to the 503A Bulks List, against FDA staff, who had recommended against listing
Pathway / Mechanistic Context Mechanistic research involving BPC-157 often focuses on biological pathways associated with vascular growth and cellular signaling
Dosing Protocols for Injury Recovery There is no FDA-approved dosing for BPC 157 and TB 500, but anecdotal use often follows patterns like: BPC 157: 200500 mcg daily, sometimes injected near the injury
The line you cannot cross is selling it or using it on people
US$ 20.87
US$ 20.95
US$ 23.26
